NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/24/2024
Back to search
Official data from USPTO
ALLIANCE CLINICAL NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
12/24/2024
Trademark type
Combined
Nice classes
42
Filing date
08/17/2023
Registration date
12/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
12/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/19/2019
First use in commerce
04/19/2019
Drawing code
3
Owner type
16
Owner location
Dallas, TX
Examiner
PODESTA, GIDETTE
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of an X-like element formed of a single line that loops back on itself in gradients of green and blue, which includes a central square and is surrounded by four circles, the left and right circles being green and the top and bottom circles being blue, all to the left of the words ALLIANCE in all blue caps stacked above the words CLINICAL NETWORK in smaller title case in blue. The color white represents background and/or transparent area and is not claimed as a part of the mark.
Holders and representatives
Holders
Alliance Clinical, LLC
Representatives
Randolph E. Digges. III RANKIN, HILL & CLARK LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Testing of pharmaceuticals; Medical and scientific research servicesthe provision of clinical trial services to biopharmaceutical companies in support of pharmaceutical product development; Medical research and scientific laboratory services for othersthe provision of clinical trial services to biopharmaceutical companies in support of pharmaceutical product development; Pharmaceutical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the nature of scientific research in the field of medicinetherapeutics and pharmaceutical developmentpsychiatryneurologyanalgesiametabolic diseases and disordersendocrinologydermatologyinfectious diseaseswomen's health; Scientific research servicesconducting clinical trials for biopharmaceutical companies in support of pharmaceutical product development; Drug discovery services; Consulting services in the field of pharmaceutical research and development; research and development services in the fields of psychiatryneurologyanalgesiametabolic diseases and disordersendocrinologydermatologyinfectious diseaseswomen's healththe provision of clinical trial services to biopharmaceutical companies in support of pharmaceutical product development; scientific research consulting services for biopharmaceutical companies in the field of designplanningimplementation project management of clinical trials in support of pharmaceutical product development
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/22/2024
PUBO
PUBLISHED FOR OPPOSITION
10/22/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/17/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/08/2024
GNRT
NON-FINAL ACTION E-MAILED
08/08/2024
CNRT
NON-FINAL ACTION WRITTEN
08/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/22/2024
GNRT
NON-FINAL ACTION E-MAILED
04/22/2024
CNRT
NON-FINAL ACTION WRITTEN
04/22/2024
DOCK
ASSIGNED TO EXAMINER
04/17/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2023
NWAP
NEW APPLICATION ENTERED
08/21/2023
Continuous trademark protection
Get notified about every new filing that threatens ALLIANCE CLINICAL NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.